The cancer cells attach to the mesothelial cells using the α5β1-integrin–fibronectin interaction, causing the activation of talin I, which is associated with the α5β1 integrin, and subsequently activates myosin-mediated contraction. The gene discussed is FN1; the disease is cancer.